1. Home
  2. SCLX vs SUUN Comparison

SCLX vs SUUN Comparison

Compare SCLX & SUUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.82

Market Cap

52.9M

Sector

Health Care

ML Signal

HOLD

SUUN

SolarBank Corporation

HOLD

Current Price

$0.66

Market Cap

61.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
SUUN
Founded
2011
2013
Country
United States
Canada
Employees
30
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.9M
61.2M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
SCLX
SUUN
Price
$6.82
$0.66
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$3.00
AVG Volume (30 Days)
41.1K
531.2K
Earning Date
04-10-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$122.52
$112.68
Revenue Next Year
$186.30
$1.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.95
$0.45
52 Week High
$34.27
$2.55

Technical Indicators

Market Signals
Indicator
SCLX
SUUN
Relative Strength Index (RSI) 45.53 50.11
Support Level $6.20 $0.45
Resistance Level $7.77 $0.74
Average True Range (ATR) 0.72 0.06
MACD 0.10 0.02
Stochastic Oscillator 71.43 50.39

Price Performance

Historical Comparison
SCLX
SUUN

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About SUUN SolarBank Corporation

PowerBank Corp is an independent renewable and clean energy project developer, power producer, and asset operator in Canada and the United States, with the majority of its revenue coming from the United States. The Company operates through two reportable segments: Development and EPC, which involves the development and construction of solar photovoltaic power projects, and IPP Production, which includes the operation of solar power and battery energy storage systems. Corporate and other activities cover operation, maintenance, and repairs. The majority of revenue is generated from the Development and EPC segment.

Share on Social Networks: